Bunalict

Bunalict is a sublingual medication combining buprenorphine and naloxone, used for opioid dependence management. This Sandoz A/S product is designed for sublingual use, offering a convenient treatment option.

Bunalict is primarily used to manage opioid dependence. The combination of buprenorphine and naloxone helps reduce withdrawal symptoms and cravings, supporting individuals in their recovery journey. This medication is intended for sublingual use, allowing for easy administration.

Common effects of Bunalict may include dizziness, nausea, and headache. Some users might experience constipation or sweating. These effects can vary from person to person, and it's important to monitor how your body responds to the medication.

Bunalict should be handled with care, especially if you have a history of liver disease or breathing problems. It's important to follow the prescribed usage guidelines and avoid sudden discontinuation. Always consult a healthcare provider before starting or stopping any medication.

Bunalict may interact with other medications, including sedatives, antidepressants, and certain pain relievers. Alcohol should be avoided while using this medication, as it can increase the risk of side effects. Always inform your healthcare provider about all medications you are taking.